In today’s episode, Dinkar Sindhu, CEO of Axis Clinicals, dives into the world of clinical research and the cautious integration of AI in drug development.
From testing groundbreaking GLP-1 drugs like Ozempic to navigating the complexities of FDA approvals, Dinkar reveals the meticulous process...